JP Morgan Maintains Overweight on BeiGene, Raises Price Target to $300
Portfolio Pulse from richadhand@benzinga.com
JP Morgan analyst Xiling Chen maintains an Overweight rating on BeiGene (NASDAQ:BGNE) and raises the price target from $297 to $300.
August 07, 2023 | 3:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan maintains an Overweight rating on BeiGene and raises the price target from $297 to $300. This could potentially lead to an increase in the stock's price.
The raised price target by JP Morgan indicates a positive outlook for BeiGene. This could lead to increased investor confidence and potentially an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100